English | Español
Patient Daily | Apr 10, 2026

Neurocrine Biosciences announces $2.9 billion acquisition of Soleno Therapeutics
Patient Daily | Apr 10, 2026

Takeda ends partnership with Denali Therapeutics on dementia drug program
Patient Daily | Apr 10, 2026

Citeline reports first decline in pharma R&D pipeline since the 1990s
Patient Daily | Apr 10, 2026

Experts discuss strategies to reduce risk in drug development at API webinar
Patient Daily | Apr 10, 2026

JMIR Publications releases article on advances in precision oncology
Patient Daily | Apr 10, 2026

Study shows how blind people map surroundings using sound
Patient Daily | Apr 10, 2026

Harvard Medical School researchers study exposome's impact on disease risk
Patient Daily | Apr 10, 2026

Mayo Clinic researchers develop method to identify proteins triggering immune responses

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'
Patient Daily | Apr 8, 2026

Breathe Free Teams Pack Meals at Community Volunteer Event, Expanding Care Beyond Clinics